CRYOPORT, INC. Operating Lease, Liability, Noncurrent
CRYOPORT, INC. (CYRX) had Operating Lease, Liability, Noncurrent of $40.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $40.08M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $39.17M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $39.08M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $39.38M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $40.08M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $39.17M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $39.08M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $39.38M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $37.44M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $38.10M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $38.55M 10-K · filed 2026-03-05 | $44.08M 10-K · filed 2025-03-07 |
| 2024-09-30 | $26.47M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $26.52M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $27.80M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $29.36M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $29.76M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $27.52M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $27.84M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $24.72M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $23.11M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $21.11M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $15.49M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $18.14M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $16.36M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $17.08M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $14.50M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $12.26M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $7.81M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $5.50M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $5.57M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $4.10M 10-K · filed 2021-03-01 | $4.10M 10-K · filed 2020-03-10 |
| 2019-09-30 | $4.27M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.92M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.62M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |